Top Authors

• Most frequent coverage on LEVP.OB

• 
  Dan Weiss (39 followers)

  • Cinryze Approved: A Significant Catalyst for Viropharma, Lev Pharmaceuticals (Sun, Oct 12)
  • Viropharma, Lev Pharmaceuticals: An Attractive Biotech Pair (Thu, Oct 9)
  • Lev Acquisition Looks Good but More Clarity Needed (Thu, Jul 17)

  More by Dan Weiss on LEVP.OB »
• 
  Value Geek (22 followers)

  • ViroPharma: Lev Acquisition Appraisal (Sun, Aug 3)

  More by Value Geek on LEVP.OB »

• Most followed authors on LEVP.OB

• 
  Dan Weiss (39 followers)

  • Cinryze Approved: A Significant Catalyst for Viropharma, Lev Pharmaceuticals (Sun, Oct 12)
  • Viropharma, Lev Pharmaceuticals: An Attractive Biotech Pair (Thu, Oct 9)
  • Lev Acquisition Looks Good but More Clarity Needed (Thu, Jul 17)

  More by Dan Weiss on LEVP.OB »
• 
  Value Geek (22 followers)

  • ViroPharma: Lev Acquisition Appraisal (Sun, Aug 3)

  More by Value Geek on LEVP.OB »

• Newest authors on LEVP.OB

• 
  Dan Weiss (39 followers)

  • Cinryze Approved: A Significant Catalyst for Viropharma, Lev Pharmaceuticals (Sun, Oct 12)
  • Viropharma, Lev Pharmaceuticals: An Attractive Biotech Pair (Thu, Oct 9)
  • Lev Acquisition Looks Good but More Clarity Needed (Thu, Jul 17)

  More by Dan Weiss on LEVP.OB »
• 
  Value Geek (22 followers)

  • ViroPharma: Lev Acquisition Appraisal (Sun, Aug 3)

  More by Value Geek on LEVP.OB »

• Most commented on LEVP.OB

• 
  Dan Weiss (39 followers)

  • Cinryze Approved: A Significant Catalyst for Viropharma, Lev Pharmaceuticals (Sun, Oct 12)
  • Viropharma, Lev Pharmaceuticals: An Attractive Biotech Pair (Thu, Oct 9)
  • Lev Acquisition Looks Good but More Clarity Needed (Thu, Jul 17)

  More by Dan Weiss on LEVP.OB »
• 
  Value Geek (22 followers)

  • ViroPharma: Lev Acquisition Appraisal (Sun, Aug 3)

  More by Value Geek on LEVP.OB »